Shares of Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €38.44 ($39.22) and traded as high as €44.15 ($45.05). Fresenius Medical Care shares last traded at €43.51 ($44.40), with a volume of 458,800 shares traded.
Fresenius Medical Care Stock Performance
The stock has a fifty day moving average of €42.76 and a 200-day moving average of €38.49. The firm has a market capitalization of $12.93 billion, a P/E ratio of 24.35, a P/E/G ratio of 0.42 and a beta of 0.86. The company has a quick ratio of 0.80, a current ratio of 1.46 and a debt-to-equity ratio of 77.56.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Further Reading
- Five stocks we like better than Fresenius Medical Care
- Business Services Stocks Investing
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- How to Calculate Return on Investment (ROI)
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Stock Average Calculator
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.